Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability

被引:147
作者
Charil, Arnaud
Dagher, Alain
Lerch, Jason P.
Zijdenbos, Alex P.
Worsley, Keith J.
Evans, Alan C.
机构
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Dept Math & Stat, Montreal, PQ H3A 2T5, Canada
关键词
D O I
10.1016/j.neuroimage.2006.10.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis (MS) is thought to predominantly affect white matter (WM). Recently, however, loss of cortical gray matter has also been described. Little is known about the cause of cortical atrophy in MS, whether it occurs early in the disease course, and whether it affects all cortical regions equally or if there is a preferential pattern of focal cortical atrophy. An automated method was used to compute the thickness at every vertex of the cortical surface of the brains of 425 early relapsing-remitting MS patients. We correlated cortical thickness with the WM lesion load and the Expanded Disability Status Scale score. Mean cortical thickness correlated with WM lesion load and disability. The correlations of cortical thickness with total lesion load and disability were most significant in cingulate gyrus, insula, and associative cortical regions. Conversely, primary sensory, visual, and motor areas showed a less significant relationship. The highest amount of atrophy per lesion volume or disability scale unit was in the anterior cingulate cortex. This study confirms the relation between cortical atrophy, WM lesion load, and disability in MS, and suggests that cortical atrophy occurs even in MS patients with only mild disability. Most interestingly, we show a specific regional pattern of focal atrophy in MS that is distinctively different from the one in normal aging. The predilection of the atrophic process for areas that are heavily interconnected with other brain regions suggests that interruption of WM tracts by MS plaques contributes, at least in part, to the development of cortical atrophy. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:509 / 517
页数:9
相关论文
共 41 条
[1]   Magnetic resonance imaging measures of brain atrophy in multiple sclerosis [J].
Anderson, VM ;
Fox, NC ;
Miller, DH .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2006, 23 (05) :605-618
[2]   Voxel-based morphometry - The methods [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2000, 11 (06) :805-821
[3]   Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings [J].
Bakshi, R ;
Benedict, RHB ;
Bermel, RA ;
Jacobs, L .
JOURNAL OF NEUROIMAGING, 2001, 11 (02) :129-136
[4]   Subpial demyelination in the cerebral cortex of multiple sclerosis patients [J].
Bo, L ;
Vedeler, CA ;
Nyland, HI ;
Trapp, BD ;
Mork, SJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (07) :723-732
[5]   Brain atrophy in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
Parker, GJM ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2002, 125 :327-337
[6]   Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets [J].
Charil, A ;
Zijdenbos, AP ;
Taylor, J ;
Boelman, C ;
Worsley, KJ ;
Evans, AC ;
Dagher, A .
NEUROIMAGE, 2003, 19 (03) :532-544
[7]   Relating neocortical pathology to disability progression in multiple sclerosis using MRI [J].
Chen, JT ;
Narayanan, S ;
Collins, DL ;
Smith, SM ;
Matthews, PM ;
Arnold, DL .
NEUROIMAGE, 2004, 23 (03) :1168-1175
[8]   Deformation-based surface morphometry applied to gray matter deformation [J].
Chung, MK ;
Worsley, KJ ;
Robbins, S ;
Paus, T ;
Taylor, J ;
Giedd, JN ;
Rapoport, JL ;
Evans, AC .
NEUROIMAGE, 2003, 18 (02) :198-213
[9]   AUTOMATIC 3D INTERSUBJECT REGISTRATION OF MR VOLUMETRIC DATA IN STANDARDIZED TALAIRACH SPACE [J].
COLLINS, DL ;
NEELIN, P ;
PETERS, TM ;
EVANS, AC .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1994, 18 (02) :192-205
[10]   Development of a multiple sclerosis functional composite as a clinical trial outcome measure [J].
Cutter, GR ;
Baier, ML ;
Rudick, RA ;
Cookfair, DL ;
Fischer, JS ;
Petkau, J ;
Syndulko, K ;
Weinshenker, BG ;
Antel, JP ;
Confavreux, C ;
Ellison, GW ;
Lublin, F ;
Miller, AE ;
Rao, SM ;
Reingold, S ;
Thompson, A ;
Willoughby, E .
BRAIN, 1999, 122 :871-882